Skip to main content
. 2025 Mar 25;32(4):192. doi: 10.3390/curroncol32040192
AE Adverse Events
AI Aromatase Inhibitor
ALN Axillary Lymph Node
CDK Cyclin-Dependent Kinase
EBC Early breast cancer
HER2− Human Epidermal Growth Factor Receptor 2-Negative
HR+ Hormone Receptor-positive
iDFS invasive Disease-Free Survival
PFS Progression-Free Survival
QoL Quality of Life
QTcF QT interval corrected for heart rate using Fridericia’s formula